Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -1116.85%, near the high end of its 5-year range (-200150.00%–78666.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -580.83%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
-580.83%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
-1116.85%
NET PROFIT MARGIN AVG 10Y
-1500.41%
NET PROFIT MARGIN AVG 15Y
-1482.60%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Benitec Biopharma Inc.
Market Cap
$304.21M
Net Profit Margin
0.00%
TTM Avg
-580.83%
3Y Avg
0.00%
5Y Avg
-1116.85%
Market Cap
$296.59M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$309.71M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
Market Cap
$287.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$288.21M
Net Profit Margin
-246.42%
TTM Avg
611.54%
3Y Avg
-783.13%
5Y Avg
-1134.34%
Market Cap
$288.33M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-348.45%
5Y Avg
-232.30%
Market Cap
$286.75M
Net Profit Margin
-103.29%
TTM Avg
-83.69%
3Y Avg
-107.92%
5Y Avg
-85.90%
Market Cap
$282.68M
Net Profit Margin
0.00%
TTM Avg
-6.08%
3Y Avg
-1303.66%
5Y Avg
-1073.20%
Market Cap
$285.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $304.21M | 0.00% | -580.83% | 0.00% | -1116.85% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $296.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.71M | -145.12% | -145.12% | -145.12% | -145.12% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $287.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.21M | -246.42% | 611.54% | -783.13% | -1134.34% |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.33M | 0.00% | 0.00% | -348.45% | -232.30% |
| Standard BioTools Inc. (LAB)vs › | $286.75M | -103.29% | -83.69% | -107.92% | -85.90% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | 0.00% | -6.08% | -1303.66% | -1073.20% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| C4 Therapeutics, Inc. (CCCC)vs › | $319.54M | -289.44% | -294.02% | -409.64% | -336.94% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -2904.14% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 78666.67% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -66585.71% |
| 2023-03-31 | -8142.59% |
| 2022-12-31 | -38650.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -6822.92% |
| 2021-12-31 | -19284.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | -200150.00% |
| 2021-03-31 | -390900.00% |
| 2020-12-31 | -325200.00% |
| 2020-09-30 | -4941.82% |
| 2020-06-30 | 7337.50% |
| 2020-03-31 | -7507.15% |
| 2019-12-31 | -2714.30% |
| 2019-09-30 | -3475.80% |
| 2019-06-30 | -228.46% |
| 2019-03-31 | -304.29% |
| 2018-12-31 | 46.08% |
| 2018-09-30 | 59.37% |
| 2018-06-30 | -266.02% |
| 2018-03-31 | -2744.07% |
| 2017-12-31 | -1693.57% |
| 2017-09-30 | -3703.86% |
| 2017-06-30 | -6308.92% |
| 2017-03-31 | -136.93% |
| 2016-12-31 | -5934.64% |
| 2016-09-30 | 872.91% |
| 2016-06-30 | -16186.32% |
| 2016-03-31 | -4115.74% |
| 2015-12-31 | -9669.18% |
| 2015-09-30 | -5487.62% |
| 2015-06-30 | -2092.40% |
| 2015-03-31 | 6241.42% |
| 2014-12-31 | -789.83% |
| 2014-09-30 | -789.83% |
| 2014-06-30 | -319.12% |
| 2014-03-31 | -319.12% |
| 2013-12-31 | -1504.51% |
| 2013-09-30 | -1504.50% |
| 2013-06-30 | -79.59% |
| 2013-03-31 | 9.18% |
| 2012-12-31 | -612.33% |
| 2012-09-30 | -617.79% |
